entity

NR1H2 (LXRβ)

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NR1H2 (LXRβ): its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections
2Hypotheses
1Analyses
3Outgoing
1Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (3)

TargetRelationTypeStr
lxr____nuclear_receptor___lipid_metabolisminvolved_inpathway0.40
neurodegenerationassociated_withdisease0.40
APOE4co_associated_withgene0.30

Incoming (1)

SourceRelationTypeStr
h-a1552ac3targetshypothesis0.50

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
LXRβ-Selective Agonism as a Precision Therapeutic for APOE4- 0.721 neurodegeneration What specific molecular mechanisms link
LXRβ-Selective Agonism Enhances CYP2J2-Mediated DHA Epoxide 0.380 lipidomics Lipid metabolism dysregulation in Alzhei

Mentioning Analyses (1)

Scientific analyses that reference this entity

What specific molecular mechanisms link APOE4 to cholesterol dysregulation in ol

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.721

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The abstract identifies APOE4's primary effect on oligodendrocyte cholesterol me

closed · Rounds: 4 · Score: 0.69 · 2026-04-16

Related Research

Hypotheses and analyses mentioning NR1H2 (LXRβ) in their description or question text

No additional research found